Pharmaceutical Supply Chain – Patent Considerations
July 28, 2022
By: Aziz Burgy, Ross Blau
American Bar Association
Axinn partner Aziz Burgy and associate Ross Blau co-authored "Pharmaceutical Supply Chain – Patent Considerations," a chapter in the third edition of the American Bar Association publication, Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio.
Click here to learn more about the publication.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
American Bar Association 2025 Asia-Pacific Conference
Speaking Engagement
Antitrust
Consumer Brands CPG Legal Forum 2025
Speaking Engagement
Antitrust
Noerr Competition Day 2025
Speaking Engagement
Antitrust
NBA Commercial Law Section 38th Annual Corporate Counsel Conference
Sponsorship
Antitrust
GCR Live: Law Leaders Global 2025
Speaking Engagement
Antitrust
The 32nd Annual Marketing Partner Forum
Event
SABA North America Corporate Counsel Retreat 2025
Sponsorship
Antitrust
Working the Headline-Grabbing Antitrust Cases as a Junior Associate with Axinn: Google Ad Tech
Speaking Engagement
Axinn Participates in Diversity Lab’s Counsel Spotlight
Diversity, Equity & Inclusion
USITC Commissioner Series: Commissioner Schmidtlein is Stepping Down, Which Could Lead to More Tailored Exclusion Orders
Axinn Viewpoints
Intellectual Property